PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Prestige Consumer Healthcare Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$49.71−0.21 (-0.42%)
Close on Oct 19, 2026
- Market cap
- $2.37B
- P/E (TTM)
- 13.9
- Dividend yield
- –
Prestige Consumer Healthcare Inc. revenue by segment
By business segment
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North American OTC Healthcare | $913.58M | $960.01M | $958.26M | $973.77M | $967.88M | $849.32M | $859.37M | $862.45M | $868.87M | $720.82M | 83.9% | -4.8% |
| International OTC Healthcare | $175.13M | $177.75M | $167.10M | $153.95M | $118.93M | $94.05M | $103.64M | $93.52M | $91.66M | $73.30M | 16.1% | -1.5% |
| Household Cleaning | – | – | – | – | – | – | $0 | $19.81M | $80.65M | $87.93M | – | – |
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | $1.08B | $1.14B | $1.13B | $1.13B | $1.09B | $943.32M | $962.94M | $975.69M | $1.04B | $881.11M | 99.6% | -4.6% |
| Gastrointestinal | $259.79M | $255.94M | $231.61M | $226.58M | $204.56M | $161.14M | $172.91M | $160.46M | $152.24M | $101.31M | 23.9% | +1.5% |
| Women's Health | $227.77M | $236.83M | $240.42M | $251.35M | $264.51M | $268.10M | $251.55M | $258.48M | $259.38M | $150.88M | 20.9% | -3.8% |
| Eye & Ear Care | $142.94M | $183.32M | $179.42M | $171.08M | $163.45M | $110.41M | $112.16M | $112.84M | $104.05M | $109.69M | 13.1% | -22.0% |
| Dermatologicals | $125.93M | $128.95M | $129.10M | $123.74M | $120.39M | $107.08M | $103.01M | $97.97M | $96.89M | $87.35M | 11.6% | -2.3% |
| Analgesics | $113.94M | $117.70M | $117.45M | $119.26M | $119.32M | $119.14M | $114.01M | $114.18M | $119.42M | $122.18M | 10.5% | -3.2% |
| Cough & Cold | $101.91M | $106.21M | $119.02M | $126.99M | $107.08M | $70.64M | $111.11M | $103.12M | $111.85M | $108.79M | 9.4% | -4.1% |
| Oral Care | $101.05M | $95.03M | $96.31M | $97.63M | $97.52M | $101.43M | $93.21M | $103.43M | $111.00M | $108.10M | 9.3% | +6.3% |
| Other OTC | $15.39M | $13.78M | $12.03M | $11.10M | $9.99M | $5.43M | $5.07M | $5.48M | $5.71M | $5.83M | 1.4% | +11.7% |
| Other revenues | $3.96M | $1.18M | $311.00K | $107.00K | $42.00K | $41.00K | $74.00K | $85.00K | $387.00K | $947.00K | 0.4% | +235.4% |
| Household Cleaning | – | – | – | – | – | – | $0 | $19.81M | $80.65M | $87.93M | – | – |
By region
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $850.41M | $897.54M | $886.47M | $953.22M | $910.11M | $799.04M | $812.65M | $837.05M | $903.51M | $769.73M | 78.1% | -5.3% |
| Rest of world | $238.29M | $240.22M | $238.89M | $174.50M | $176.71M | $144.33M | $150.36M | $138.73M | $137.67M | $112.33M | 21.9% | -0.8% |
From the segment and revenue-disaggregation notes of Prestige Consumer Healthcare's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.